Thanks again longreach …
This site says the first leadless dual chamber system was FDA approved in July 2023 - the Aveir from Abbott
https://cardiovascularbusiness.com/...-first-dual-chamber-leadless-pacemaker-system
https://www.abbott.com/corpnewsroom...stem-3-things-to-know-after-FDA-approval.html
According to the last EBR presentation the WiSE implant is substantially smaller which is good …. So I guess that would make EBR an ideal takeover candidate (despite what John McCutcheon said in one of the links you posted) .
This article from 18/07/24 says analysts have given Abbott, the Aveir developer (a diverse medical gadgets etc company ) an ‘outperform’ rating but no mention gets made of how many of those dual chamber units have been sold…
https://www.investing.com/news/comp...rform-rating-on-solid-q2-results-93CH-3525558
cheers
General Investor Information EBR Systems, page-328
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.030(2.88%) |
Mkt cap ! $372.8M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | $1.01 | $66.24K | 64.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4247 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 6000 | 1 |
View Market Depth
| Last trade - 15.10pm 01/11/2024 (20 minute delay) ? |
| EBR (ASX) Chart |